期刊文献+

铁死亡在心肌缺血再灌注损伤中作用研究进展 被引量:11

Role of ferroptosis in myocardial ischemia-reperfusion injury
原文传递
导出
摘要 铁死亡是一种铁依赖的程序性细胞死亡方式,铁死亡诱导的内质网应激在铁死亡与其他类型的细胞死亡之间发挥重要串联作用。铁死亡诱导内质网应激过程中的未折叠蛋白质反应,随后激活PERK-eIF2α-ATF4-CHOP信号通路。C/EBP同源蛋白信号通路可介导内质网应激凋亡过程,其在心肌缺血再灌注损伤过程中发挥重要作用。p53上调凋亡调控因子的过程是p53非依赖性的,同时参与铁死亡与细胞凋亡间的协同关系。本文就内质网应激介导的PERK-eIF2α-ATF4-CHOP-PUMA途径在铁死亡和心肌缺血再灌注过程中作用的研究进展作一综述。 Ferroptosis is an iron-dependent method of programmed cell death. It has been found that ferroptosis-induced endoplasmic reticulum stress(ERS) plays an important tandem role between iron death and other types of cell death. Ferroptosis induces an unfolded protein response during ERS, followed by activating PERK-eIF2α-ATF4-CHOP signaling pathway. The C/EBP homologous protein(CHOP) signaling pathway mediates ERS apoptosis, functioning in the ischemia-reperfusion injury process. p53 upregulated modulator of apoptosis(PUMA) is p53-independent, and is involved in the synergistic relationship between iron death and apoptosis. This paper reviews the role of ERS-mediated PERK-eIF2α-ATF4-CHOP-PUMA pathway in ferroptosis and myocardial ischemia-reperfusion.
作者 李文远 夏中元 李维 雷少青 冷燕 LI Wenyuan;XIA Zhongyuan;LI Wei;LEI Shaoqing;LENG Yan(Department of Anesthesiology,Renmin Hospital of Wuhan University,Wuhan 430060,China)
出处 《中华实用诊断与治疗杂志》 2019年第6期607-610,共4页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(81671891)
关键词 心肌缺血再灌注 铁死亡 内质网应激 ferroptosis endoplasmic reticulum stress myocardial ischemia-reperfusion injury
  • 相关文献

参考文献5

二级参考文献49

  • 1Charytan C, Bernardo MV, Koch T A, etal. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study[J]. Nephro] Dial Transplant,2013,28(4) :953-964.
  • 2Qunibi W Y, Martinez C, Smith M, et al. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis- dependent chronic kidney disease patients [J]. Nephrol Dial Transplant, 2011,26 (5) :1599-1607.
  • 3Skikne B S, Punnonen K, Caldron P H, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index[J]. Am J Hematol,2011,86(11) :923-927.
  • 4National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J] Am J Kidney Dis,2002,39(2 Suppl 1) :S1 266.
  • 5Levey A S, Bosch J P, Lewis J B, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Grou[J]. Ann Intern Med, 1999,130(6): 461-470.
  • 6WikstrOm B, Bhandari S, Barany P, et al. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease[J]. J Nephrol,2011,24(5) :589-596.
  • 7Leonard A J, Patterson A J, Collins C E, et al. Is soluble transferrin receptor a useful marker in early stage iron deficiency? [J]. eSPENJ,2013,8(5)~e210 e212.
  • 8Go A S, Chertow G M, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization [J]. NEnglJ Med,2004,351(13):1296-1305.
  • 9Keith D S, Nichols G A, Gullion C M, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization[J]. Arch Intern Med, 2004,164 (6) .. 659-663.
  • 10Groenendyk J, Agellon LB,Michalak M. Coping with endoplasmic reticulum stress in the cardiovascular system. Annu Rev Physiol, 2013,75:49.

共引文献207

同被引文献56

引证文献11

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部